AGER and chronic obstructive pulmonary disease: Our immunohistochemical data confirm and extend previously published findings that showed moderate to high expression of RAGE in the alveolar region, with low expression in the bronchial epithelium [31, 32] and higher expression in lung tissue from patients with COPD[9, 10].